Prostate Cancer Registry and Research Study
Part of Cancer clinical trials.
This study collects medical information and tissue samples from men with prostate cancer to better understand the disease and improve future treatment. You'll provide consent and allow researchers to use your health data and biopsy samples for studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with high-risk localized prostate cancer (elevated PSA, aggressive cell type, or advanced stage) OR metastatic prostate cancer (cancer spread confirmed by imaging or biopsy)
- Have prostate adenocarcinoma (the most common type of prostate cancer)
- Age 18 or older
- Able to give written informed consent
- Speak Dutch, English, Arabic, or Turkish
- Currently living in the Netherlands
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a database of people with localized or locally advanced prostate cancer to better understand patient-reported outcomes (your experiences and quality-of-life). It may help improve future care by collecting consistent feedback from patients.
This study follows people with newly diagnosed prostate cancer to understand care decisions and outcomes over the long term. It uses routine medical information and asks you to complete questionnaires, which may help improve future treatment and support.
This registry collects information from people with prostate cancer to help researchers better understand the disease and improve future treatments.
This study is a European registry that collects information from men with prostate cancer who need advanced imaging (like PSMA PET/CT or MRI) to check if the cancer has spread. By joining, you help researchers learn more about how these scans improve care.
This study is a worldwide registry that collects health information from men with advanced prostate cancer. It may help researchers better understand disease patterns and outcomes, which can guide future treatments.
This is a registry study that follows men with low-risk prostate cancer who choose active surveillance instead of immediate treatment. It helps doctors understand how safe and effective active surveillance is, including confirming results with repeat biopsies.
Hear when a new High-Risk Localized Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.